discuss note last night acut hospit segment under-perform
expect weak attribut flat inpati surgic volum
growth stand even context particularli strong
same-stor admiss growth surgic weak notabl higher
acuiti high margin orthoped cardiac servic line advers mix effect less
surgic medic admit result rev/adj admit declin
weak pin specif driver tougher comp high-deduct plan
discuss potenti explan take comfort weak jan/feb
surgic volum seemingli recov march within recoveri
preliminarili persist april howev also note jan/feb surgic
weak geograph widespread across portfolio oppos
concentr one two major region conclus could
neg read hospit oper
assum stretch beyond may anomali
addit call detail guidanc reiter manag note
coupl penni light vs intern budget surgic volum
normal weak earli start also note behavior segment modestli
outperform same-stor revenu growth near top-end guidanc
rang cost come modestli better expect length stay pressur
persist howev manag expect shift medicaid manag
remain headwind next year repurchas share
quarter guidanc assum repo could move somewhat
higher doj settlement done follow result reduc
forward estim incorpor soft reduc ebitda
estim bln bln ebitda bln
bln chang pt still ebitda view
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
perform well howev behavior segment
struggl hit same-stor growth target due
tight labor market clinician drag ebitda
behavior volum same-stor revenu rebound
hit growth target lead stronger
ebitda growth multipl expans
behavior growth deceler difficulti
recruit retain clinician persist lead
weaker expect ebitda
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
acut segment under-perform quarter due weak inpati surgic
growth flat y/i compar recent trend growth despit surgic
procedur weak medic admiss quit strong result strong same-stor
inpati admiss growth also first look
rel weak higher pay surgic volum howev led declin
revenu per adj admiss result ebitda light consensu estim
half miss vs consensu attribut street estim ahead
compani intern budget qtr manag indic quarter
coupl penni short ep vs intern budget driven acut care ebitda
short intern plan behavior modestli ahead
servic line cite surgic weak includ orthoped hip knee spine
cardio stent open heart pacemak respons question call manag
acknowledg long held view high deduct plan increasingli shift
procedur volum away earli month year toward end year
patient hit deduct dynam play least last sever
year howev may play small part januari weak
would anticip high deduct plan delay non-elect cardiolog procedur
also worth point industri overal experienc higher rel acuiti
earli part last year may prove difficult comp year
behavior segment perform modestli ahead expect larg due slightli
lower cost growth labor cost pressur remain manag see pressur
last coupl year store revenu growth top end
guidanc rang howev length stay remain pressur declin
quarter manag continu expect pressur evolut medicaid ff
toward manag medicaid take anoth year abat behavior admiss trend
grew line howev length stay declin result growth
full year guidanc remain unchang larg due compani expect
recoveri surgic volum surgic volum improv cours
quarter januari character weak sequenti improv
month point march april run back normal level acuiti
last quarter reserv relat depart justic on-going investig
certain behavior facil increas bring total accrual
recal fals claim act investig on-going sinc least
comment recent investor confer manag remain optimist
settlement would reach note gap uhss settlement offer
govern demand narrow consider although offer timelin
conclus manag reiter view call morn note
focu discuss govern last coupl month shift
nonmonetari term settlement suggest accrual
balanc sheet may near ultim liabil paid compani
 incom statement total wage oper rental high-tech ebitda incom ebit expens rate ep barclay
 incom statement total wage oper rental high-tech reimburs revenuenoncontrol ebitda incom ebit expens rate ep barclay
steve valiquett patrick feeley herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli
indirectli relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
